Reduction of GBM43 migration following STAT3 inhibition validated previous studies where STAT3 silencing impaired the migration of gastric carcinoma[26] and GBM cells[25,67,73], likely due to decreased activity of RhoA and matrix metalloproteinases (MMPs) expression[74]. The gene discussed is STAT3; the disease is glioblastoma.